PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology, Ann Romney Center for Neurologic Diseases, Partners Multiple Sclerosis Center, Brigham and Women\'s Hospital, Harvard Medical School, 60 Fenwood Road, Mailbox 9002L, Boston, MA, 02115, USA.\', \'Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.\', \'Department of Neurology, University of Massachusetts, Worcester, MA, USA.\', \'Department of Neurology, Maine Medical Center, Portland, ME, USA.\', \'Department of Neurology, Concord Hospital, Concord, NH, USA.\', \'Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.\', \'University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, ON, Canada.\', \'Vita-Salute San Raffaele University, Milan, Italy.\', \'Department of Neurology, Ann Romney Center for Neurologic Diseases, Partners Multiple Sclerosis Center, Brigham and Women\'s Hospital, Harvard Medical School, 60 Fenwood Road, Mailbox 9002L, Boston, MA, 02115, USA. rbakshi@post.harvard.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00415-020-09944-8
?:doi
?:hasPublicationType
?:journal
  • Journal of neurology
is ?:pmid of
?:pmid
?:pmid
  • 32494856
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.626
?:rankingScore_hIndex
  • 118
?:title
  • COVID-19 in teriflunomide-treated patients with multiple sclerosis.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all